AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio

Contributed by: PR Newswire

Tags

AbbVie

More Like This

Vertex Enters Into Agreement to Acquire Alpine Immune Sciences

PR Newswire associated0

Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

Vertex Announces Key Advancements Across Kidney Portfolio

Oblique Therapeutics has entered a research collaboration agreement with Eli Lilly and Company to apply the AbiProt® technology to generate antibodies to a high-value target

Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

PR Newswire associated0

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

PR Newswire associated0

Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies